Investor Relations

IR Home

IR Home

Recent News
11/17/22
Conformis’ Imprint™ knee system introduces the new “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA) BILLERICA, Mass. , Nov. 17, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement
11/14/22
Conformis Settles Medacta Litigation Related to Patient-Specific Instruments BILLERICA, Mass. , Nov. 14, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license agreement with Medacta USA , Medacta Germany GmbH , and Medacta
Upcoming Events
More events are coming soon.
IR Contact  
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com